The benchmark index is within a whisker of breaching its record close touched in January 2022 and on track to post its biggest quarterly ga...

In a study, a combination of tiragolumab and Roche's established Tecentriq drug did not slow disease progression in newly diagnosed cases o...

Biocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel.